VACCINE STRAIN OF INFLUENZA A/17/KANSAS/2017/631 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN

摘要

FIELD: biotechnology.;SUBSTANCE: invention relates to the field of biotechnology. Invention is a vaccine strain A/17/Kansas/2017/631 (H3N2) - a reassortant produced by crossing epidemic virus A/Kansas/14/2017 (H3N2) with a cold-adapted temperature-sensitive virus A/Leningrad/134/17/57 (H2N2) - an attenuation donor, which is harmless for humans.;EFFECT: proposed strain can be used for preventing influenza in both adults and children from the age of three.;1 cl, 5 tbl, 1 dwg